Founded Year
2003Stage
Acquired | AcquiredTotal Raised
$25MAbout SupplyScape
SupplyScape aims to provide electronic pedigree solutions to enable the pharmaceutical industry to secure their supply chains and to comply with regulations to limit drug counterfeiting.On August 23, 2009, SupplyScape was acquired by TraceLink. The terms of the transaction were not disclosed.
SupplyScape Headquarter Location
500 Unicorn Park Drive Suite 102
Woburn, Massachusetts, 01801,
United States
781-305-8085
Latest SupplyScape News
Nov 4, 2020
TraceLink has acquired SupplyScape, a provider of products and services to secure the supply chain, and plans to improve its track and trace offering. SupplyScape provides services to help pharma companies with tasks including project design and development, implementation and performance optimisation. These services will now be provided as part of TraceLink, which is funded by FirstMark Capital. TraceLink believes that using this financial backing SupplyScape will be better equipped to serve its clients and further its ePedigree and RxAuthentication software. All TraceLink’s employees used to work at SupplyScape. Financial details of the deal have not been disclosed. Copyright - Unless otherwise stated all contents of this web site are © 2020 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
When was SupplyScape founded?
SupplyScape was founded in 2003.
Where is SupplyScape's headquarters?
SupplyScape's headquarters is located at 500 Unicorn Park Drive, Woburn.
What is SupplyScape's latest funding round?
SupplyScape's latest funding round is Acquired.
How much did SupplyScape raise?
SupplyScape raised a total of $25M.
Who are the investors of SupplyScape?
Investors of SupplyScape include TraceLink, North Bridge Venture Partners, Flybridge Capital Partners, Pilot House Ventures, Pfizer Venture Investments and 3 more.
Who are SupplyScape's competitors?
Competitors of SupplyScape include InClinica, TraceLink, Combinent BioMedical Systems, Sequel Pharmaceuticals, Acton Pharmaceuticals and 13 more.
You May Also Like
Advent Pharmaceuticals is a specialty pharmaceutical company focused on developing inhaled drug products using a dry powder inhalation delivery system. The products are mostly used for the treatment of asthma and other respiratory diseases.
Kytogenics is a medical device company. It had developed the Nocc Hydrophilic Wound Dressing.Kytogenics Pharmaceuticals, Inc. is a biomedical company engaged in the development of products based on its medical device and drug delivery patented platform technology.
Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.
Century Pharmaceuticals is a generic drug manufacturer based in India.
IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.
AkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.